Φορτώνει......

Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials

STUDY QUESTION: Can asoprisnil, a selective progesterone receptor modulator, provide clinically meaningful improvements in heavy menstrual bleeding (HMB) associated with uterine fibroids with an acceptable safety profile? SUMMARY ANSWER: Uninterrupted treatment with asoprisnil for 12 months effectiv...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:	Hum Reprod
Κύριοι συγγραφείς:	Stewart, E A, Diamond, M P, Williams, A R W, Carr, B R, Myers, E R, Feldman, R A, Elger, W, Mattia-Goldberg, C, Schwefel, B M, Chwalisz, K
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Oxford University Press 2019
Θέματα:	Original Article
Διαθέσιμο Online:	https://ncbi.nlm.nih.gov/pmc/articles/PMC7967793/ https://ncbi.nlm.nih.gov/pubmed/30865281 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/humrep/dez007
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials

Παρόμοια τεκμήρια